Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A safety and proof of concept efficacy Phase 1b/2a trial of 10XB101

Trial Profile

A safety and proof of concept efficacy Phase 1b/2a trial of 10XB101

Planning
Phase of Trial: Phase I/II

Latest Information Update: 30 Apr 2018

At a glance

  • Drugs 10XB 101 (Primary)
  • Indications Obesity
  • Focus Adverse reactions; First in man; Proof of concept; Therapeutic Use
  • Most Recent Events

    • 30 Apr 2018 New trial record
    • 02 Apr 2018 According to 10xBio media release, the company anticipates to initiate the trial in the the first quarter this this year and completion by the end of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top